Wedbush analyst David Nierengarten initiated coverage with a Buy rating on Kura Oncology (KURA – Research Report) today and set a price target ...

Today, about one-third of office space in downtown LA sits empty. It’s a far cry from the once-booming real estate market in ...

Tesla (NASDAQ:TSLA – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at Wedbush in a report issued on Monday,Benzinga reports. They presently have a $400 ...

Nvidia has reported a surge in third-quarter profit and sales as demand for its specialized computer chips that power ...

Elon Musk's ties to the Trump administration pose potential conflicts of interest for his various businesses that have ...

New company unveils futuristic boat — and its flagship product seems straight out of a sci-fi movie ...

which Wedbush President Gary Wedbush told the LA Times had “recovered more fully from the pandemic than downtown Los Angeles has” – a factor that also played a role in the firm’s decision ...

Tesla, Inc. ($TSLA) shares rose sharply in premarket trading on Monday after a Bloomberg report said President-elect Donald ...

The new company will include the USA Network, CNBC, MSNBC, Oxygen, E!, SYFY and the Golf Channel. Comcast will retain key ...

Many organizations have put in place return-to-office policies, but only a fraction of them actively enforce the rules.

Tesla's stock continues to climb as the Trump administration plans to ease regulations on self-driving cars, signaling a ...

Canaccord Genuity Group reiterated their buy rating on shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) in a ...